Rathnasinghe, Raveen
Jangra, Sonia
Miorin, Lisa
Schotsaert, Michael
Yahnke, Clifford
Garcίa-Sastre, Adolfo
Funding for this research was provided by:
CEIRS (HHSN272201400008C)
JPB Foundation, the Open Philanthropy Project (2020-215611 (5384))
Article History
Received: 25 March 2021
Accepted: 26 August 2021
First Online: 30 September 2021
Competing interests
: The García-Sastre Laboratory has received research support from Pfizer, Senhwa Biosciences, 7Hills Pharma, Avimex, Blade Therapeutics, Dynavax, ImmunityBio, Nanocomposix and Kenall Manufacturing. Adolfo García-Sastre has consulting agreements for the following companies involving cash and/or stock: Vivaldi Biosciences, Pagoda, Contrafect, 7Hills Pharma, Avimex, Vaxalto, Accurius, Pfizer and Esperovax. RR, CY and AGS have filed for a provisional patent based upon these results.